Loading...
单中心晚期非小细胞肺癌免疫治疗真实世界数据分析
BACKGROUND AND OBJECTIVE: In recent years, a number of clinical trials have shown that immunocheckpoint inhibitors (ICI) have brought survival benefits to patients with advanced non-small cell lung cancer (NSCLC), however, such clinical trials comprise cohorts selected based on strict and complex en...
Na minha lista:
| Udgivet i: | Zhongguo Fei Ai Za Zhi |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
中国肺癌杂志编辑部
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6885419/ https://ncbi.nlm.nih.gov/pubmed/31771737 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3779/j.issn.1009-3419.2019.11.02 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|